Oxytocin Market Is Expected To Reach USD 36.4 Billion By 2027 At A CAGR Of 5.4 Percent.
Stellar Market Research has published a report on the Oxytocin Market that provides a detailed analysis for the forecast period of 2021 to 2027.
Oxytocin Market Scope:
The report comprises thorough insights into the market for industry stakeholders which includes an interpretation of complex market data in simple language, the industry’s historical and current state, along with estimated market size and trends. The report explores all segments of the industry, with a focus on significant players e.g. market leaders, followers, and new entrants. The report covers a detailed PESTLE analysis for different countries. A clear representation of the competitive landscape of key players by products and services, revenue, financial position, portfolio, growth strategies, and regional presence in the Oxytocin market make the report an investor’s guide.
Request Free Sample:@https://www.stellarmr.com/report/req_sample/Oxytocin-Market/321
Oxytocin Market Overview:
Because of its importance in human evolution, the neuropeptide hormone oxytocin has inspired a surge in commercial interest. The peptide hormone is involved in a wide range of physiological processes. It aids in the process of delivery, nursing, and mother behaviour, among other things. For example, the oxytocin industry has grown as a result of an investigation into widening oxytocin’s activities beyond birth induction.
Oxytocin Market Dynamics:
The competition for the international oxytocin business has picked up considerably. This is largely due to researchers investigating the role of oxytocin in human well-being, specifically how essential it may be in regulating social behaviours and changing emotions in humans and other species. Exogenous oxytocin has been demonstrated to improve a wide range of social behaviours. The healthcare industry, in particular, is betting on oxytocin’s huge potential in the treatment of acute and chronic diseases, as a cancer indicator, and in the creation of a wide range of therapies, including analgesics.
The need for synthetic oxytocin has increased as the number of C-sections has increased, helped by FDA-approved versions. Human disease research has been a key indicator of the expanding commercial potential of the oxytocin sector. A flurry of neurobiological investigations has delved into new paths in novel treatment strategies for mental disorders in recent years, with oxytocin contributing to the development of new therapeutic targets. As a result, the oxytocin industry has created new revenue streams for people suffering from autism, schizophrenia, borderline personality disorder, and social anxiety disorders.
An increasing interest in social cognition is one of the key factors driving the oxytocin industry. The increasing number of placebo studies is hastening market growth. Neuroimaging technological advancements have driven significant progress in this discipline. Several animal studies have extended the oxytocin market’s potential. Furthermore, the rise in induced births in poorer nations has increased the demand for clinics and institutional delivery in many parts of the world. Improvements in the neurobiology of oxytocin effects are expected to raise revenue potential in the oxytocin industry throughout the forecast period.
Oxytocin Market Regional Analysis:
Due to growing rates of delivery and pregnancy-related complications, the North American oxytocin industry exceeded $5 billion in sales by 2020. According to Blue Cross Blue Shield, pregnant women with pre-existing ailments are becoming increasingly prevalent. Furthermore, the number of women experiencing both birth and pregnancy complications increased by more than 30% between 2014 and 2018. According to the report, the top causes of pregnancy problems are pre-eclampsia (19%) and gestational diabetes (16.6%). In response to these changes, pharmaceutical manufacturers in the United States are boosting synthetic oxytocin production.
In terms of revenue, the European oxytocin market is estimated to grow at a pace of approximately 8% by 2027. Substantial advancements in maternity care have contributed to an increase in oxytocin product sales across the region. Between 2000 and 2015, the maternal mortality rate declined by approximately half, from 33 to 15 deaths per 100,000 live births. Women of ‘non-western’ origin, on the other hand, have a mortality rate that is 60% higher than their European counterparts.
Oxytocin Market Segmentation:
By Indication:
By Distribution Channel:
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
Oxytocin Market Key Competitors:
- Pfizer Inc.
- Novartis AG
- Fresenius Kabi LLC
- Hikma Pharmaceuticals PLC
- Endo International Plc.
- Teva Pharmaceuticals Ltd.
- Mylan N.V.
- Wockhardt Ltd.
- Sun Pharmaceutical Industries Ltd.
- Yuhan Corporation
To Get A Sample Of The Oxytocin Market, Click Here:@https://www.stellarmr.com/report/Oxytocin-Market/321
About Stellar Market Research:
Stellar Market Research, established in 2018, is an India-based consulting firm that focuses on supporting customers with company transformation goals through advisory services and long-term planning. The business uses its extensive industry knowledge and huge network to provide insightful views on reports that provide customers with a strategic advantage. Its heavy emphasis on secondary market analysis, consumer purchasing patterns, and price fluctuations offers clients a market portfolio that will enable their organization to gain a permanent presence or strategize solutions and take the course of action that will result in incredible growth and market dominance.
Contact Stellar Market Research:
S.no.8, h.no. 4-8 Pl.7/4, Kothrud,
Pinnac Memories Fl. No. 3, Kothrud,
Pune, Pune, Maharashtra, 411029
